CN102240330B - Medicinal composition for strengthening bones - Google Patents

Medicinal composition for strengthening bones Download PDF

Info

Publication number
CN102240330B
CN102240330B CN2011102235012A CN201110223501A CN102240330B CN 102240330 B CN102240330 B CN 102240330B CN 2011102235012 A CN2011102235012 A CN 2011102235012A CN 201110223501 A CN201110223501 A CN 201110223501A CN 102240330 B CN102240330 B CN 102240330B
Authority
CN
China
Prior art keywords
parts
grams
medicinal composition
pharmaceutical composition
fracture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2011102235012A
Other languages
Chinese (zh)
Other versions
CN102240330A (en
Inventor
梁兴涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011102235012A priority Critical patent/CN102240330B/en
Publication of CN102240330A publication Critical patent/CN102240330A/en
Application granted granted Critical
Publication of CN102240330B publication Critical patent/CN102240330B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicinal composition for strengthening bones. The medicinal composition comprises the following Chinese herbal medicines in part by weight: 20 parts of Chinese angelica, 10 parts of safflower, 10 parts of tree peony bark, 12 parts of ground beetle, 10 parts of yanhusuo, 15 parts of dragon bone, 15 parts of oyster, 20 parts of fortune's drynaria rhizome, 15 parts of eucommia bark and 6 parts of liquoric root. The medicinal composition has the effects of nourishing liver and kidney, tonifying qi and blood and promoting the union of fracture.

Description

A kind of pharmaceutical composition of bone strengthening
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of pharmaceutical composition of bone strengthening.
Background technology
In daily life, people are often perplexed by osteopathia, wherein especially with the recovery etc. after the fracture for very.In order to solve these miseries, people have carried out a large amount of research, but effect is not desirable especially.
Summary of the invention
The pharmaceutical composition that the purpose of this invention is to provide a kind of bone strengthening.
In order to realize purpose of the present invention, the invention provides a kind of pharmaceutical composition of bone strengthening, it comprises following crude drug by weight: 6 parts in 20 parts of Radix Angelicae Sinensis, 10 parts on Flos Carthami, 10 parts of Cortex Moutans, 12 parts of eupolyphaga, 10 parts of Rhizoma Corydalis, 15 parts of Os Draconis, 15 parts of Concha Ostreaes, 20 parts of Rhizoma Drynariae, 15 parts of the Cortexs Eucommiae and Radix Glycyrrhizae.
Preferably, the pharmaceutical composition of bone strengthening of the present invention also comprises following crude drug by weight: 7 10 parts of 7 10 parts of Eriocheir sinensiss and clasps.
Preferably, the pharmaceutical composition of bone strengthening of the present invention can be made tablet, dispersible tablet, pill or unguentum.
Pharmaceutical composition nourishing the liver and kidney of the present invention, compensate qi and blood, the recovery from illness when promoting fracture.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 pill of the present invention
Get Radix Angelicae Sinensis 20 grams, Flos Carthami 10 grams, Cortex Moutan 10 grams, eupolyphaga 12 grams, Rhizoma Corydalis 10 grams, Os Draconis 15 grams, Concha Ostreae 15 grams, Rhizoma Drynariae 20 grams, the Cortex Eucommiae 15 grams and Radix Glycyrrhizae 6 grams, be ground into fine powder, cross 80 mesh sieves, mixing.Every 100g powder adds the water of refined honey 40g and 10 grams, general ball, and drying is made 100 pills.
The preparation of embodiment 2 pills of the present invention
Get Radix Angelicae Sinensis 20 grams, Flos Carthami 10 grams, Cortex Moutan 10 grams, eupolyphaga 12 grams, Rhizoma Corydalis 10 grams, Os Draconis 15 grams, Concha Ostreae 15 grams, Rhizoma Drynariae 20 grams, the Cortex Eucommiae 15 grams, Radix Glycyrrhizae 6 grams, Eriocheir sinensis 7 10 grams and clasp 7 10 grams, be ground into fine powder, cross 80 mesh sieves, mixing.Every 100g powder adds the water of refined honey 40g and 10 grams, general ball, and drying is made 100 pills.
Experimental example
Choose 54 routine patients, male 31 examples, women 23 examples; Age 19-64 year, average 40.3 years old; Fracture of femur 19 examples, fracture of tibia 25 examples, humeral fracture 7 examples, ulnar fracture 3 examples; Course of disease 6-24 month, average 11.2 months; Loose type 26 examples of nonunion type, atrophic type 28 examples.Be divided into two groups, every group of 27 routine patients.
Diagnostic criteria: fracture delayed union refers to that the fracture of a foot position and type fails healing within its average time (usually 3-6 month), as actively effectively not treating, then may form bone does not connect.Clinical manifestation for suffer from the limb rest pain, unstable, use unable.Limbs have abnormal movement or pseudarthrosis during inspection.Can there be edema and tenderness in the part.It is clear that X-ray film shows as fracture line, and without callus formation, the bone does not connect X-ray film shows as the epiphysis sclerosis, the medullary cavity sealing, and two fracture ends form pestle mortar shape pseudarthrosis sometimes.Sometimes fracture end atrophy is loose, and the epiphysis gap increases.
The pill of preparation in the pill of first group of oral embodiment 1 preparation, second group of oral embodiment 2.Every day 3 times, each 10.30 days is a course for the treatment of.
Observe limbs pain, swelling, the movable and silly growing state of bone of patient treatment front and back.Clap respectively X-ray film in contrast before and after the treatment.
The criterion of therapeutical effect produce effects: sx↓, limb activity can, X-ray film shows that fracture line is fuzzy, bone is silly to be formed.Effectively: sx↓, but limbs gentle activity, X-ray film show that fracture line is fuzzy or a small amount of callus formation are arranged.Invalid: symptom has no and alleviates, and limb activity is poor, and X-ray film shows that fracture line exists, and has no obvious callus formation.
After treating a course for the treatment of, for the pill of embodiment 1,17 routine produce effects, 10 examples are effectively.For the pill of embodiment 2,27 routine produce effects.
After healing, all patients are followed up a case by regular visits to once weekly, in one month, do not find patient's disease relapse and significantly untoward reaction.

Claims (2)

1. the pharmaceutical composition of a bone strengthening, it is characterized in that it is made by following crude drug by weight: 7 10 parts of 20 parts of Radix Angelicae Sinensis, 10 parts on Flos Carthami, 10 parts of Cortex Moutans, 12 parts of eupolyphaga, 10 parts of Rhizoma Corydalis, 15 parts of Os Draconis, 15 parts of Concha Ostreaes, 20 parts of Rhizoma Drynariae, 15 parts of the Cortexs Eucommiae, 6 parts in Radix Glycyrrhizae, 7 10 parts of Eriocheir sinensiss and clasps.
2. the pharmaceutical composition of bone strengthening according to claim 1 is characterized in that, described pharmaceutical composition is made tablet, pill or unguentum.
CN2011102235012A 2011-08-05 2011-08-05 Medicinal composition for strengthening bones Active CN102240330B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011102235012A CN102240330B (en) 2011-08-05 2011-08-05 Medicinal composition for strengthening bones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011102235012A CN102240330B (en) 2011-08-05 2011-08-05 Medicinal composition for strengthening bones

Publications (2)

Publication Number Publication Date
CN102240330A CN102240330A (en) 2011-11-16
CN102240330B true CN102240330B (en) 2013-03-20

Family

ID=44958690

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011102235012A Active CN102240330B (en) 2011-08-05 2011-08-05 Medicinal composition for strengthening bones

Country Status (1)

Country Link
CN (1) CN102240330B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103735676B (en) * 2014-01-16 2015-09-16 贾忠 A kind of compound Chinese medicinal preparation for the treatment of traumatic injury and its preparation method and application

Also Published As

Publication number Publication date
CN102240330A (en) 2011-11-16

Similar Documents

Publication Publication Date Title
CN103083500A (en) Chinese medicinal composition treating toxoplasmosis
CN103120738A (en) Medicinal composition for treating ischemic cerebral apoplexy
CN102240330B (en) Medicinal composition for strengthening bones
CN103585457B (en) A kind of medicament for the treatment of fracture
CN1324650A (en) Effective medicine for treating cervical vertebra disease as one kind of intractable disease
CN102283972B (en) Pharmaceutical composition for treating rib fracture
CN102335307A (en) Traditional Chinese medicinal composition able to relax muscles, stimulate blood circulation, disperse blood stasis and relieve pain, and its preparation method
CN101194985B (en) Orally taken Chinese medicine composition for treating articulatio genus hyperosteogeny
CN102552503B (en) Traditional Chinese medicine powder used for treating cervical erosion
CN104055860A (en) Medicine for tonifying liver and kidney and strengthening bones and musculatures
CN101904992B (en) Chinese medicinal preparation for treating traumatic injury
KR20020066242A (en) A herb medicine for treating an arthritis
CN102579617A (en) Traditional Chinese medicine capsule for treating chronic neck, shoulder, waist and leg pains and processing method of same
CN103623085B (en) Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof
CN101385844B (en) Traditional Chinese medicine composition for treating the hemorrhoids and preparation method thereof
CN101862398A (en) Chinese medicament for treating osteoporosis
CN105168415A (en) Preparation for relieving pain in neck, waist and bones
CN104984170A (en) Application of traditional Chinese medicine composite in treating rabies
CN102526506B (en) Medicament for treating osteopathia
CN1313110C (en) Oteoproliferation treating plaster and preparation method thereof
CN103127236B (en) Traditional Chinese medicine compound for treatment of rheumatic arthritis and preparation method thereof
CN103142960B (en) Medicament for treating skin diseases
CN103393961A (en) Traditional Chinese medicine for treating cervical spondylosis and preparation method thereof
CN103623084B (en) Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof
CN103070998B (en) Externally-applied plaster for curing pain of rheumatic joints

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant